Kipp A. Weiskopf

Internal Medicine

75 Francis St
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma.

High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma.

Journal: Nature communications

Published: May 04, 2026

Targeting the CD47/SIRPα interaction in cancer: opportunities in non-Hodgkin lymphoma.

Targeting the CD47/SIRPα interaction in cancer: opportunities in non-Hodgkin lymphoma.

Journal: Expert opinion on investigational drugs

Published: March 11, 2026

Haruka Resolves Perturbation Response Heterogeneity in Spatial Cell Niches.

Haruka Resolves Perturbation Response Heterogeneity in Spatial Cell Niches.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2026

Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.

Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 03, 2025

CD47 predominates over CD24 as a macrophage immune checkpoint in cancer.

CD47 predominates over CD24 as a macrophage immune checkpoint in cancer.

Journal: bioRxiv : the preprint server for biology

Published: December 09, 2024

Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma.

Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2024

Phagocytic cooperativity by tumour macrophages.

Phagocytic cooperativity by tumour macrophages.

Journal: Nature biomedical engineering

Published: September 07, 2023

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.

Journal: bioRxiv : the preprint server for biology

Published: March 22, 2023

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.

Journal: The Journal of clinical investigation

Published: February 07, 2023

MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis.

MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis.

Journal: Cell reports

Published: September 16, 2022

Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center.

Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center.

Journal: Circulation. Heart failure

Published: October 30, 2019

Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade.

Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade.

Journal: Melanoma research

Published: June 18, 2019

Showing 1-12 of 44

Last Updated: 09/26/2026